Bioactive Peptide IRW in Egg White Hydrolysate for Metabolic Syndrome Mitigation

This study explores a special protein fragment called IRW, found in egg whites, which might help improve health by activating a key enzyme known as ACE2. ACE2 is important because it helps protect the heart and metabolism and is known as the entry point for some viruses, including the coronavirus. By activating ACE2, IRW could potentially help manage conditions like high blood pressure and type-2 diabetes. This research is important because it aims to turn egg whites into a functional food that could help mitigate metabolic syndrome, offering a new dietary strategy for these conditions. Participants in this trial will consume a product made from egg white hydrolysate, where IRW is expected to be released in the body with the help of digestive enzymes. The study will examine how well IRW is absorbed and its effectiveness in humans. By using whole egg whites as a starting material, the study aims to create an affordable and practical dietary solution. The trial will focus on assessing the bioavailability and health benefits of IRW, providing insights into its potential as a valuable dietary addition.